103
Participants
Start Date
June 16, 2021
Primary Completion Date
January 31, 2028
Study Completion Date
June 30, 2030
Gabrinox
"Regimen: GEMBRAX~Other Names:~Albumin bound paclitaxel 125 mg/m² + Gemcitabine 1000 mg/m²~Regimen: FOLFIRINOX~Other Names:~Oxaliplatin 85 mg/m² + Leucovorin 200 mg/m² + Irinotecan 180 mg/m² + 5FU bolus 400mg/m² + 5FU continuous 2400 mg/m²~Gembrax + Folfirinox = GABRINOX"
MRI-GUIDED STEREOTACTIC RADIOTHERAPY
"Radiotherapy will start between 5 and 6 weeks after the last injection of chemotherapy (FOLFIRINOX regimen) in non-progressive patients after Gabrinox.~Stereotactic adaptive radiotherapy in five fractions: prescription of five fractions of 10 Gy/each on the planning target volume (PTV). At least two sessions/week should be performed. An interval of at least 18 hours between fractions is recommended."
RECRUITING
Institut Paoli Calmettes, Marseille
RECRUITING
Centre Georges-François Leclerc, Dijon
RECRUITING
CHU Carémeau, Nîmes
RECRUITING
CHU Saint-Eloi, Montpellier
RECRUITING
Institut régional du Cancer de Montpellier, Montpellier
NOT_YET_RECRUITING
Centre Eugène Marquis, Rennes
RECRUITING
Hôpital Pitié Salpétriêre, Paris
NOT_YET_RECRUITING
Hôpital Beaujon, Clichy
NOT_YET_RECRUITING
Hopital Paul Brousse, Villejuif
Institut du Cancer de Montpellier - Val d'Aurelle
OTHER